CIK 0001826667 · Non-accelerated filer<br>Smaller reporting company
TriSalus Life Sciences, Inc.
Sign in to watch- Ticker
- TLSI
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 853009869
- Phone
- 415 336 8917
- Business address
- 6272 WEST 91ST AVENUE, WESTMINSTER, CO, 80031
- Former names
- MedTech Acquisition Corp, MedTech Acquisition Corporation
Securities
- TLSI Common Stock Nasdaq
- TLSIW Warrant Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,113
- in 3 filings
Net −$4,113. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 26 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-05 | Cox Bryan F. Chief of Research | Sale | −296 | $4.39 | $1K | 162,805 |
| 2026-10-05 | Marshak Richard Chief Commercial Officer | Sale | −325 | $4.39 | $1K | 127,994 |
| 2026-10-05 | Stevens Jennifer Chief Regulatory Officer | Sale | −316 | $4.39 | $1K | 123,794 |
| 2026-05-15 | Marshak Richard Chief Commercial Officer | Sale | −543 | $2.67 | $1K | 125,101 |
| 2026-03-17 | Szela Mary T CEO and President | Sale | −15,944 | $3.85 | $61K | 752,987 |
| 2026-03-16 | Devlin Jodi Chief of Clinical Operations | Sale | −273 | $4.12 | $1K | 97,364 |
| 2026-03-16 | Cox Bryan F. Chief of Research | Sale | −579 | $4.12 | $2K | 163,415 |
| 2026-03-16 | Marshak Richard Chief Commercial Officer | Sale | −419 | $4.12 | $2K | 110,397 |
| 2026-03-16 | Stevens Jennifer Chief Regulatory Officer | Sale | −774 | $4.12 | $3K | 124,110 |
| 2026-03-12 | Devlin Jodi Chief of Clinical Operations | Sale | −1,772 | $4.09 | $7K | 97,637 |
| 2026-03-12 | Cox Bryan F. Chief of Research | Sale | −1,467 | $4.09 | $6K | 163,994 |
| 2026-03-12 | Marshak Richard Chief Commercial Officer | Sale | −1,589 | $4.09 | $6K | 110,816 |
| 2026-03-12 | Stevens Jennifer Chief Regulatory Officer | Sale | −1,552 | $4.09 | $6K | 124,884 |
| 2026-03-11 | Devlin Jodi Chief of Clinical Operations | Sale | −1,162 | $4.13 | $5K | 99,409 |
| 2026-03-11 | Cox Bryan F. Chief of Research | Sale | −1,138 | $4.13 | $5K | 165,461 |
| 2026-03-11 | Marshak Richard Chief Commercial Officer | Sale | −1,449 | $4.13 | $6K | 112,405 |
| 2026-03-11 | Stevens Jennifer Chief Regulatory Officer | Sale | −1,204 | $4.13 | $5K | 126,436 |
| 2026-03-11 | Szela Mary T CEO and President | Sale | −4,358 | $4.13 | $18K | 768,931 |
| 2025-05-19 | Cox Bryan F. Chief of Research | Sale | −4,764 | $5.18 | $25K | 119,415 |
| 2025-05-19 | Devlin Jodi Chief of Clinical Operations | Sale | −4,764 | $5.18 | $25K | 52,764 |
Page 1 of 2 · 25 trades